{"id":10174,"date":"2026-05-27T06:33:49","date_gmt":"2026-05-27T11:33:49","guid":{"rendered":"https:\/\/nanostherapeutics.com\/?p=10174"},"modified":"2026-05-27T06:38:04","modified_gmt":"2026-05-27T11:38:04","slug":"nanoscope-therapeutics-selects-inspirogene-by-mckesson-to-support-distribution-of-novel-retinal-therapy","status":"publish","type":"post","link":"https:\/\/nanostherapeutics.com\/ja\/2026\/05\/27\/nanoscope-therapeutics-selects-inspirogene-by-mckesson-to-support-distribution-of-novel-retinal-therapy\/","title":{"rendered":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u3001\u65b0\u898f\u7db2\u819c\u6cbb\u7642\u85ac\u306e\u8ca9\u58f2\u652f\u63f4\u306e\u305f\u3081\u30de\u30c3\u30b1\u30bd\u30f3\u793e\u306e\u30a4\u30f3\u30b9\u30d4\u30ed\u30b8\u30fc\u30f3\u793e\u3092\u9078\u5b9a"},"content":{"rendered":"
\n\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\r\n\t\t\t\t\t\t\t\t
\r\n\r\n\t\t\t\t\r\n\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

\u30c0\u30e9\u30b9<\/span>,\u00a0<\/strong>5\u670827\u65e5,<\/strong> 2026 <\/strong><\/span>\u2014\u00a0\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u682a\u5f0f\u4f1a\u793e<\/a>, \u7db2\u819c\u5909\u6027\u306b\u3088\u308b\u5149\u53d7\u5bb9\u4f53\u55aa\u5931\u304a\u3088\u3073\u8996\u899a\u969c\u5bb3\u306e\u60a3\u8005\u5411\u3051\u306b\u3001\u75be\u60a3\u3092\u554f\u308f\u306a\u3044\u65b0\u898f\u6cbb\u7642\u6cd5\u306e\u958b\u767a\u304a\u3088\u3073\u5546\u696d\u5316\u306b\u6ce8\u529b\u3059\u308b\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u3067\u3042\u308b[\u4f01\u696d\u540d]\u306f\u672c\u65e5\u3001\u4e3b\u529b\u88fd\u54c1\u3067\u3042\u308bMOGENRY\u2122\u306e\u7c73\u56fd\u306b\u304a\u3051\u308b\u5546\u696d\u5316\u30b5\u30fc\u30d3\u30b9\u3092\u3001\u7c73\u56fd\u898f\u5236\u5f53\u5c40\u306e\u627f\u8a8d\u3092\u6761\u4ef6\u3068\u3057\u3066\u3001McKesson\u5098\u4e0b\u306eInspiroGene\u306b\u59d4\u8a17\u3059\u308b\u3053\u3068\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002.<\/p>

InspiroGene\u306f\u3001\u5c02\u9580\u85ac\u5c40\u3001\u5c02\u9580\u6d41\u901a\u3001\u304a\u3088\u3073\u60a3\u8005\u30cf\u30d6\u30b5\u30fc\u30d3\u30b9\u3092\u901a\u3058\u3066\u3001Nanoscope\u304c\u958b\u767a\u4e2d\u306e\u7db2\u819c\u75be\u60a3\u6cbb\u7642\u85ac\u306e\u7c73\u56fd\u306b\u304a\u3051\u308b\u6d41\u901a\u3092\u652f\u63f4\u3057\u307e\u3059\u3002\u3053\u306e\u63d0\u643a\u306f\u3001Nanoscope\u304c\u7c73\u56fd\u5e02\u5834\u5411\u3051\u306b\u521d\u306e\u5149\u907a\u4f1d\u5b66\u7684\u907a\u4f1d\u5b50\u6cbb\u7642\u85ac\u3092\u767a\u58f2\u3059\u308b\u306b\u3042\u305f\u308a\u3001\u60a3\u8005\u3068\u533b\u7642\u63d0\u4f9b\u8005\u306b\u6700\u9ad8\u6c34\u6e96\u306e\u4f53\u9a13\u3092\u63d0\u4f9b\u3059\u308b\u3053\u3068\u3092\u76ee\u7684\u3068\u3057\u305f\u3001\u7c73\u56fd\u306b\u304a\u3051\u308b\u5546\u696d\u5316\u304a\u3088\u3073\u30b5\u30d7\u30e9\u30a4\u30c1\u30a7\u30fc\u30f3\u30b5\u30fc\u30d3\u30b9\u306b\u91cd\u70b9\u3092\u7f6e\u3044\u3066\u3044\u307e\u3059\u3002.\u00a0<\/p>

\u201c\u300c\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u793e\u306f\u3001\u60a3\u8005\u3055\u3093\u306e\u751f\u6d3b\u306e\u8cea\u306e\u5411\u4e0a\u306b\u660e\u78ba\u306a\u30b3\u30df\u30c3\u30c8\u30e1\u30f3\u30c8\u3092\u6301\u3061\u3001\u5353\u8d8a\u3057\u305f\u79d1\u5b66\u7814\u7a76\u3092\u9032\u3081\u3066\u3044\u307e\u3059\u300d\u3068\u3001\u30de\u30c3\u30b1\u30bd\u30f3\u793e\u306e\u7d30\u80de\u30fb\u907a\u4f1d\u5b50\u30fb\u5148\u9032\u6cbb\u7642\u90e8\u9580\u8cac\u4efb\u8005\u3067\u3042\u308b\u30b8\u30e7\u30fc\u30fb\u30c7\u30d4\u30f3\u30c8\u6c0f\u306f\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002\u300c\u30de\u30c3\u30b1\u30bd\u30f3\u5098\u4e0b\u306e\u30a4\u30f3\u30b9\u30d4\u30ed\u30b8\u30fc\u30f3\u306f\u3001\u3053\u308c\u3089\u306e\u6cbb\u7642\u6cd5\u306e\u767a\u5c55\u3092\u652f\u63f4\u3059\u308b\u3068\u3068\u3082\u306b\u3001\u60a3\u8005\u3055\u3093\u3084\u533b\u7642\u63d0\u4f9b\u8005\u304c\u30d0\u30ea\u30e5\u30fc\u30c1\u30a7\u30fc\u30f3\u3092\u7406\u89e3\u3057\u3001\u3053\u308c\u3089\u306e\u91cd\u8981\u306a\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u3092\u5229\u7528\u3067\u304d\u308b\u3088\u3046\u30b5\u30dd\u30fc\u30c8\u3067\u304d\u308b\u3053\u3068\u3092\u8a87\u308a\u306b\u601d\u3044\u307e\u3059\u3002\u300d\u2019<\/p>

\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u793e\u306e\u81e8\u5e8a\u30d7\u30ed\u30b0\u30e9\u30e0\u306f\u3001\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\u3092\u542b\u3080\u7db2\u819c\u5909\u6027\u75be\u60a3\u306e\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u3066\u304a\u308a\u3001\u6e80\u305f\u3055\u308c\u3066\u3044\u306a\u3044\u91cd\u8981\u306a\u533b\u7642\u30cb\u30fc\u30ba\u306b\u5bfe\u5fdc\u3057\u3066\u3044\u307e\u3059\u3002\u540c\u793e\u306e\u30a2\u30d7\u30ed\u30fc\u30c1\u306f\u3001\u5916\u79d1\u7684\u30a4\u30f3\u30d7\u30e9\u30f3\u30c8\u3084\u5149\u5897\u611f\u88c5\u7f6e\u3092\u4f7f\u7528\u305b\u305a\u306b\u4f7f\u7528\u3067\u304d\u308b\u3088\u3046\u306b\u8a2d\u8a08\u3055\u308c\u3066\u304a\u308a\u3001\u5c02\u9580\u533b\u7642\u65bd\u8a2d\u306b\u304a\u3051\u308b\u6cbb\u7642\u306e\u30ed\u30b8\u30b9\u30c6\u30a3\u30af\u30b9\u3092\u7c21\u7d20\u5316\u3057\u307e\u3059\u3002.<\/p>

\u201c\u300cInspiroGene\u3068\u306e\u9023\u643a\u306f\u3001\u5f53\u793e\u306e\u88fd\u54c1\u5316\u6e96\u5099\u8a08\u753b\u306b\u304a\u3051\u308b\u91cd\u8981\u306a\u4e00\u6b69\u3067\u3059\u300d\u3068\u3001Nanoscope Therapeutics\u306eCEO\u3067\u3042\u308bSulagna Bhattacharya\u6c0f\u306f\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002\u300cInspiroGene\u306f\u3001\u5305\u62ec\u7684\u306a\u60a3\u8005\u30b5\u30dd\u30fc\u30c8\u306e\u7d4c\u9a13\u3068\u3001\u7c73\u56fd\u306e\u533b\u7642\u30b7\u30b9\u30c6\u30e0\u5168\u4f53\u306b\u308f\u305f\u308b\u5c02\u9580\u77e5\u8b58\u3092\u6709\u3057\u3066\u304a\u308a\u3001\u898f\u5236\u5f53\u5c40\u306e\u627f\u8a8d\u5f8c\u306e\u52b9\u7387\u7684\u306a\u88fd\u54c1\u63d0\u4f9b\u3092\u652f\u63f4\u3059\u308b\u4e0a\u3067\u6709\u5229\u306a\u7acb\u5834\u306b\u3042\u308a\u307e\u3059\u3002\u300d\u201d<\/p>

\u672c\u5951\u7d04\u306f\u3001\u767a\u58f2\u6e96\u5099\u3001\u5728\u5eab\u7ba1\u7406\u3001\u6ce8\u6587\u51e6\u7406\u3001\u304a\u3088\u3073\u9069\u7528\u3055\u308c\u308b\u898f\u5236\u8981\u4ef6\u3068\u54c1\u8cea\u8981\u4ef6\u306e\u9075\u5b88\u3092\u652f\u63f4\u3059\u308b\u3053\u3068\u3092\u76ee\u7684\u3068\u3057\u3066\u3044\u307e\u3059\u3002.<\/p>

MCO\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306b\u3064\u3044\u3066<\/b><\/p>

MCO\u306f\u3001\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\uff08RP\uff09\u3001\u30b9\u30bf\u30fc\u30ac\u30eb\u30c8\u75c5\uff08SD\uff09\u3001\u5730\u56f3\u72b6\u840e\u7e2e\u75c7\uff08GA\uff09\u306a\u3069\u306e\u5149\u53d7\u5bb9\u4f53\u5909\u6027\u75c7\u60a3\u8005\u306e\u8996\u529b\u56de\u5fa9\u3092\u76ee\u7684\u3068\u3057\u305f\u3001\u6cbb\u9a13\u6bb5\u968e\u306e\u5358\u56de\u6295\u4e0e\u578b\u785d\u5b50\u4f53\u5185\u6295\u4e0e\u7642\u6cd5\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002MCO\u306f\u3001\u9ad8\u5bc6\u5ea6\u306e\u53cc\u6975\u7db2\u819c\u7d30\u80de\u3092\u6d3b\u6027\u5316\u3057\u3066\u5149\u611f\u53d7\u6027\u3092\u6301\u305f\u305b\u308b\u3053\u3068\u3067\u3001\u5149\u53d7\u5bb9\u4f53\u7d30\u80de\u6b7b\u5f8c\u306e\u65e2\u5b58\u306e\u8996\u899a\u56de\u8def\u3092\u5229\u7528\u3057\u307e\u3059\u3002MCO\u6cbb\u7642\u306f\u3001\u907a\u4f1d\u5b50\u691c\u67fb\u3001\u4fb5\u8972\u7684\u306a\u624b\u8853\u3001\u307e\u305f\u306f\u7e70\u308a\u8fd4\u3057\u6295\u4e0e\u3092\u5fc5\u8981\u3068\u3057\u306a\u3044\u305f\u3081\u3001\u60a3\u8005\u306e\u6cbb\u7642\u8ca0\u62c5\u3092\u8efd\u6e1b\u3057\u3001\u65e2\u5b58\u306e\u7db2\u819c\u8a3a\u7642\u30ef\u30fc\u30af\u30d5\u30ed\u30fc\u5185\u3067\u5e45\u5e83\u3044\u60a3\u8005\u306b\u9069\u7528\u53ef\u80fd\u3067\u3059\u3002.<\/p>

\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u306b\u3064\u3044\u3066<\/b><\/p>

\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u306f\u3001\u7db2\u819c\u5909\u6027\u75be\u60a3\u306b\u3088\u308a\u5931\u660e\u3057\u305f\u6570\u767e\u4e07\u4eba\u306e\u60a3\u8005\u306e\u305f\u3081\u306b\u3001\u75be\u60a3\u3092\u554f\u308f\u306a\u3044\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u5149\u907a\u4f1d\u5b66\u7684\u6cbb\u7642\u6cd5\u3092\u958b\u767a\u3057\u3066\u3044\u307e\u3059\u3002\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\uff08RP\uff09\uff08NCT04945772<\/a>\uff09\u3001FDA\u3078\u306eBLA\u7533\u8acb\u304c\u9806\u6b21\u958b\u59cb\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u627f\u8a8d\u3055\u308c\u308c\u3070\u3001MCO-010\u306f\u907a\u4f1d\u5b50\u691c\u67fb\u3092\u5fc5\u8981\u3068\u305b\u305a\u3001\u8a3a\u7642\u6240\u30671\u56de\u6ce8\u5c04\u3059\u308b\u3060\u3051\u3067\u6295\u4e0e\u3067\u304d\u308b\u305f\u3081\u3001RP\u60a3\u8005\u306e\u6a19\u6e96\u6cbb\u7642\u3068\u306a\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002\u540c\u793e\u306f\u307e\u305f\u3001\u30b9\u30bf\u30fc\u30ac\u30eb\u30c8\u75c5\uff08SD\uff09\uff08NCT05417126<\/a>\uff09\u3092\u958b\u59cb\u3057\u3001\u00a0\u30d5\u30a7\u30fc\u30ba3\u767b\u9332\u8a66\u9a13<\/a>\u00a02026\u5e74\u306b\u958b\u59cb\u4e88\u5b9a\u3067\u3059\u3002MCO-010\u306f\u3001\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\uff08RP\uff09\u3068\u30b9\u30bf\u30d5\u30a3\u30f3\u30fb\u30c7\u30a3\u30d5\u30a3\u30b7\u30eb\u75c7\uff08SD\uff09\u306e\u4e21\u65b9\u3067FDA\u306e\u30d5\u30a1\u30b9\u30c8\u30c8\u30e9\u30c3\u30af\u304a\u3088\u3073\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3092\u53d7\u3051\u3066\u304a\u308a\u3001SD\u306b\u3064\u3044\u3066\u306fRMAT\u6307\u5b9a\u3082\u53d7\u3051\u3066\u3044\u307e\u3059\u3002\u307e\u305f\u3001\u907a\u4f1d\u6027\u7db2\u819c\u30b8\u30b9\u30c8\u30ed\u30d5\u30a3\u30fc\uff08IRD\uff09\u306b\u3064\u3044\u3066\u306fPMDA\u306e\u5148\u99c6\u3051\u6307\u5b9a\u304a\u3088\u3073\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3001IRD\u306b\u3064\u3044\u3066\u306fEMA\u304a\u3088\u3073SFDA\u306e\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3082\u53d7\u3051\u3066\u3044\u307e\u3059\u3002\u5730\u7406\u7684\u840e\u7e2e\uff08GA\uff09\u306b\u5bfe\u3059\u308bMCO\u306e\u7b2c2\u76f8\u30d7\u30ed\u30b0\u30e9\u30e0\u306f2026\u5e74\u306b\u958b\u59cb\u4e88\u5b9a\u3067\u3059\u3002IND\u7533\u8acb\u6e96\u5099\u4e2d\u306e\u305d\u306e\u4ed6\u306e\u30d7\u30ed\u30b0\u30e9\u30e0\u306b\u306f\u3001\u30ec\u30fc\u30d0\u30fc\u5148\u5929\u6027\u9ed2\u5185\u969c\uff08LCA\uff09\u304c\u3042\u308a\u307e\u3059\u3002.<\/p>

\u63a5\u89e6\uff1a
<\/b>\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e
+1 (817) 857-1186
PR@nanostherapeutics.com<\/a>\u00a0<\/p>

\u51fa\u5178\uff1a\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30c3\u30af<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\r\n\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t<\/section>\r\n\t\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

DALLAS,\u00a0May 27, 2026 \u2014\u00a0Nanoscope Therapeutics Inc., a biotechnology company focused on developing and commercializing novel, disease\u2011agnostic therapies for patients with photoreceptor loss and vision impairment due to retinal degeneration, today announced that it has selected InspiroGene by McKesson to provide U.S. commercialization services for its lead product, MOGENRY\u2122, subject to U.S. regulatory approval. InspiroGene will support the U.S. distribution of Nanoscope\u2019s anticipated retinal therapy through its specialty pharmacy, specialty distribution, and patient hub services. The collaboration is focused on US commercialization and supply chain services to provide a best-in-class experience for patients and providers as Nanoscope launches the first optogenetic gene therapy for the US market.\u00a0 \u201cNanoscope is advancing extraordinary […]<\/p>\n","protected":false},"author":1,"featured_media":10175,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[13,8],"tags":[],"class_list":["post-10174","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-home-page","category-nanoscope-press-release"],"yoast_head":"\nNanoscope Therapeutics Selects InspiroGene by McKesson to Support Distribution of Novel Retinal Therapy - Nanoscope Therapeutics<\/title>\n<meta name=\"description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanostherapeutics.com\/ja\/2026\/05\/27\/nanoscope-therapeutics-selects-inspirogene-by-mckesson-to-support-distribution-of-novel-retinal-therapy\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanoscope Therapeutics Selects InspiroGene by McKesson to Support Distribution of Novel Retinal Therapy - Nanoscope Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanostherapeutics.com\/ja\/2026\/05\/27\/nanoscope-therapeutics-selects-inspirogene-by-mckesson-to-support-distribution-of-novel-retinal-therapy\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanoscope Therapeutics\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-27T11:33:49+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-27T11:38:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/06\/NSCOPE_nu_Logo_Horizontal_2Color_1200px.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"242\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Wilson PJ\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:site\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Wilson PJ\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"3\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/05\\\/27\\\/nanoscope-therapeutics-selects-inspirogene-by-mckesson-to-support-distribution-of-novel-retinal-therapy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/05\\\/27\\\/nanoscope-therapeutics-selects-inspirogene-by-mckesson-to-support-distribution-of-novel-retinal-therapy\\\/\"},\"author\":{\"name\":\"Wilson PJ\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/2fa4c7d9fcf90c2c01f1341935baf02d\"},\"headline\":\"Nanoscope Therapeutics Selects InspiroGene by McKesson to Support Distribution of Novel Retinal Therapy\",\"datePublished\":\"2026-05-27T11:33:49+00:00\",\"dateModified\":\"2026-05-27T11:38:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/05\\\/27\\\/nanoscope-therapeutics-selects-inspirogene-by-mckesson-to-support-distribution-of-novel-retinal-therapy\\\/\"},\"wordCount\":541,\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/05\\\/27\\\/nanoscope-therapeutics-selects-inspirogene-by-mckesson-to-support-distribution-of-novel-retinal-therapy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/NSCOPE_LI_INSPIROGENE_Patient.jpg\",\"articleSection\":[\"Home Page\",\"Nanoscope Press Release\"],\"inLanguage\":\"ja\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/05\\\/27\\\/nanoscope-therapeutics-selects-inspirogene-by-mckesson-to-support-distribution-of-novel-retinal-therapy\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/05\\\/27\\\/nanoscope-therapeutics-selects-inspirogene-by-mckesson-to-support-distribution-of-novel-retinal-therapy\\\/\",\"name\":\"Nanoscope Therapeutics Selects InspiroGene by McKesson to Support Distribution of Novel Retinal Therapy - Nanoscope Therapeutics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/05\\\/27\\\/nanoscope-therapeutics-selects-inspirogene-by-mckesson-to-support-distribution-of-novel-retinal-therapy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/05\\\/27\\\/nanoscope-therapeutics-selects-inspirogene-by-mckesson-to-support-distribution-of-novel-retinal-therapy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/NSCOPE_LI_INSPIROGENE_Patient.jpg\",\"datePublished\":\"2026-05-27T11:33:49+00:00\",\"dateModified\":\"2026-05-27T11:38:04+00:00\",\"description\":\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/05\\\/27\\\/nanoscope-therapeutics-selects-inspirogene-by-mckesson-to-support-distribution-of-novel-retinal-therapy\\\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/05\\\/27\\\/nanoscope-therapeutics-selects-inspirogene-by-mckesson-to-support-distribution-of-novel-retinal-therapy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/05\\\/27\\\/nanoscope-therapeutics-selects-inspirogene-by-mckesson-to-support-distribution-of-novel-retinal-therapy\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/NSCOPE_LI_INSPIROGENE_Patient.jpg\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/NSCOPE_LI_INSPIROGENE_Patient.jpg\",\"width\":1200,\"height\":627},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/05\\\/27\\\/nanoscope-therapeutics-selects-inspirogene-by-mckesson-to-support-distribution-of-novel-retinal-therapy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nanostherapeutics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nanoscope Therapeutics Selects InspiroGene by McKesson to Support Distribution of Novel Retinal Therapy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"name\":\"Nanoscope Therapeutics\",\"description\":\"Bringing Back the Light of Hope\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"alternateName\":\"Nanoscope Therapeutics\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanostherapeutics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\",\"name\":\"Nanoscope Therapeutics, Inc\",\"alternateName\":\"Nanoscope Therapeutics\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"width\":512,\"height\":435,\"caption\":\"Nanoscope Therapeutics, Inc\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/NSTherapeutics\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/nanoscope\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/2fa4c7d9fcf90c2c01f1341935baf02d\",\"name\":\"Wilson PJ\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u3001\u65b0\u898f\u7db2\u819c\u6cbb\u7642\u85ac\u306e\u8ca9\u58f2\u652f\u63f4\u306e\u305f\u3081\u30de\u30c3\u30b1\u30bd\u30f3\u793e\u306e\u30a4\u30f3\u30b9\u30d4\u30ed\u30b8\u30fc\u30f3\u793e\u3092\u9078\u5b9a - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanostherapeutics.com\/ja\/2026\/05\/27\/nanoscope-therapeutics-selects-inspirogene-by-mckesson-to-support-distribution-of-novel-retinal-therapy\/","og_locale":"ja_JP","og_type":"article","og_title":"Nanoscope Therapeutics Selects InspiroGene by McKesson to Support Distribution of Novel Retinal Therapy - Nanoscope Therapeutics","og_description":"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.","og_url":"https:\/\/nanostherapeutics.com\/ja\/2026\/05\/27\/nanoscope-therapeutics-selects-inspirogene-by-mckesson-to-support-distribution-of-novel-retinal-therapy\/","og_site_name":"Nanoscope Therapeutics","article_published_time":"2026-05-27T11:33:49+00:00","article_modified_time":"2026-05-27T11:38:04+00:00","og_image":[{"width":1200,"height":242,"url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/06\/NSCOPE_nu_Logo_Horizontal_2Color_1200px.jpg","type":"image\/jpeg"}],"author":"Wilson PJ","twitter_card":"summary_large_image","twitter_creator":"@NSTherapeutics","twitter_site":"@NSTherapeutics","twitter_misc":{"\u57f7\u7b46\u8005":"Wilson PJ","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"3\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nanostherapeutics.com\/2026\/05\/27\/nanoscope-therapeutics-selects-inspirogene-by-mckesson-to-support-distribution-of-novel-retinal-therapy\/#article","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/2026\/05\/27\/nanoscope-therapeutics-selects-inspirogene-by-mckesson-to-support-distribution-of-novel-retinal-therapy\/"},"author":{"name":"Wilson PJ","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/2fa4c7d9fcf90c2c01f1341935baf02d"},"headline":"Nanoscope Therapeutics Selects InspiroGene by McKesson to Support Distribution of Novel Retinal Therapy","datePublished":"2026-05-27T11:33:49+00:00","dateModified":"2026-05-27T11:38:04+00:00","mainEntityOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2026\/05\/27\/nanoscope-therapeutics-selects-inspirogene-by-mckesson-to-support-distribution-of-novel-retinal-therapy\/"},"wordCount":541,"publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2026\/05\/27\/nanoscope-therapeutics-selects-inspirogene-by-mckesson-to-support-distribution-of-novel-retinal-therapy\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/NSCOPE_LI_INSPIROGENE_Patient.jpg","articleSection":["Home Page","Nanoscope Press Release"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/nanostherapeutics.com\/2026\/05\/27\/nanoscope-therapeutics-selects-inspirogene-by-mckesson-to-support-distribution-of-novel-retinal-therapy\/","url":"https:\/\/nanostherapeutics.com\/2026\/05\/27\/nanoscope-therapeutics-selects-inspirogene-by-mckesson-to-support-distribution-of-novel-retinal-therapy\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u3001\u65b0\u898f\u7db2\u819c\u6cbb\u7642\u85ac\u306e\u8ca9\u58f2\u652f\u63f4\u306e\u305f\u3081\u30de\u30c3\u30b1\u30bd\u30f3\u793e\u306e\u30a4\u30f3\u30b9\u30d4\u30ed\u30b8\u30fc\u30f3\u793e\u3092\u9078\u5b9a - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2026\/05\/27\/nanoscope-therapeutics-selects-inspirogene-by-mckesson-to-support-distribution-of-novel-retinal-therapy\/#primaryimage"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2026\/05\/27\/nanoscope-therapeutics-selects-inspirogene-by-mckesson-to-support-distribution-of-novel-retinal-therapy\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/NSCOPE_LI_INSPIROGENE_Patient.jpg","datePublished":"2026-05-27T11:33:49+00:00","dateModified":"2026-05-27T11:38:04+00:00","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","breadcrumb":{"@id":"https:\/\/nanostherapeutics.com\/2026\/05\/27\/nanoscope-therapeutics-selects-inspirogene-by-mckesson-to-support-distribution-of-novel-retinal-therapy\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanostherapeutics.com\/2026\/05\/27\/nanoscope-therapeutics-selects-inspirogene-by-mckesson-to-support-distribution-of-novel-retinal-therapy\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/2026\/05\/27\/nanoscope-therapeutics-selects-inspirogene-by-mckesson-to-support-distribution-of-novel-retinal-therapy\/#primaryimage","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/NSCOPE_LI_INSPIROGENE_Patient.jpg","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/NSCOPE_LI_INSPIROGENE_Patient.jpg","width":1200,"height":627},{"@type":"BreadcrumbList","@id":"https:\/\/nanostherapeutics.com\/2026\/05\/27\/nanoscope-therapeutics-selects-inspirogene-by-mckesson-to-support-distribution-of-novel-retinal-therapy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nanostherapeutics.com\/"},{"@type":"ListItem","position":2,"name":"Nanoscope Therapeutics Selects InspiroGene by McKesson to Support Distribution of Novel Retinal Therapy"}]},{"@type":"WebSite","@id":"https:\/\/nanostherapeutics.com\/#website","url":"https:\/\/nanostherapeutics.com\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5e0c\u671b\u306e\u5149\u3092\u53d6\u308a\u623b\u3059","publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"alternateName":"Nanoscope Therapeutics","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanostherapeutics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/nanostherapeutics.com\/#organization","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e","alternateName":"Nanoscope Therapeutics","url":"https:\/\/nanostherapeutics.com\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","width":512,"height":435,"caption":"Nanoscope Therapeutics, Inc"},"image":{"@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/NSTherapeutics","https:\/\/www.linkedin.com\/company\/nanoscope"]},{"@type":"Person","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/2fa4c7d9fcf90c2c01f1341935baf02d","name":"\u30a6\u30a3\u30eb\u30bd\u30f3 PJ"}]}},"_links":{"self":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/10174","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/comments?post=10174"}],"version-history":[{"count":4,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/10174\/revisions"}],"predecessor-version":[{"id":10179,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/10174\/revisions\/10179"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media\/10175"}],"wp:attachment":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media?parent=10174"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/categories?post=10174"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/tags?post=10174"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}